Global Biosimilar Drug Market Analysis and Forecast 2024-2030

Global Biosimilar Drug Market Analysis and Forecast 2024-2030


Summary

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.
A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

According to APO Research, The global Biosimilar Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Biosimilar Drug is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Biosimilar Drug include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius, Amgen, Eli Lilly, Sandoz, Changchun High Tech and Innovent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biosimilar Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Biosimilar Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Biosimilar Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biosimilar Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biosimilar Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Biosimilar Drug sales, projected growth trends, production technology, application and end-user industry.

Biosimilar Drug segment by Company

CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
Biosimilar Drug segment by Type

Injection
Tablets
Other Types
Biosimilar Drug segment by Application

Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
Biosimilar Drug segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilar Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biosimilar Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilar Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Biosimilar Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Biosimilar Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosimilar Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Biosimilar Drug Market by Type
1.2.1 Global Biosimilar Drug Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Biosimilar Drug Market by Application
1.3.1 Global Biosimilar Drug Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Biosimilar Drug Market Dynamics
2.1 Biosimilar Drug Industry Trends
2.2 Biosimilar Drug Industry Drivers
2.3 Biosimilar Drug Industry Opportunities and Challenges
2.4 Biosimilar Drug Industry Restraints
3 Global Market Growth Prospects
3.1 Global Biosimilar Drug Revenue Estimates and Forecasts (2019-2030)
3.2 Global Biosimilar Drug Revenue by Region
3.2.1 Global Biosimilar Drug Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Biosimilar Drug Revenue by Region (2019-2024)
3.2.3 Global Biosimilar Drug Revenue by Region (2025-2030)
3.2.4 Global Biosimilar Drug Revenue Market Share by Region (2019-2030)
3.3 Global Biosimilar Drug Sales Estimates and Forecasts 2019-2030
3.4 Global Biosimilar Drug Sales by Region
3.4.1 Global Biosimilar Drug Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Biosimilar Drug Sales by Region (2019-2024)
3.4.3 Global Biosimilar Drug Sales by Region (2025-2030)
3.4.4 Global Biosimilar Drug Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Biosimilar Drug Revenue by Manufacturers
4.1.1 Global Biosimilar Drug Revenue by Manufacturers (2019-2024)
4.1.2 Global Biosimilar Drug Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Biosimilar Drug Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Biosimilar Drug Sales by Manufacturers
4.2.1 Global Biosimilar Drug Sales by Manufacturers (2019-2024)
4.2.2 Global Biosimilar Drug Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Biosimilar Drug Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Biosimilar Drug Sales Price by Manufacturers (2019-2024)
4.4 Global Biosimilar Drug Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Biosimilar Drug Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Biosimilar Drug Manufacturers, Product Type & Application
4.7 Global Biosimilar Drug Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Biosimilar Drug Market CR5 and HHI
4.8.2 2023 Biosimilar Drug Tier 1, Tier 2, and Tier 3
5 Biosimilar Drug Market by Type
5.1 Global Biosimilar Drug Revenue by Type
5.1.1 Global Biosimilar Drug Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Biosimilar Drug Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Biosimilar Drug Revenue Market Share by Type (2019-2030)
5.2 Global Biosimilar Drug Sales by Type
5.2.1 Global Biosimilar Drug Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Biosimilar Drug Sales by Type (2019-2030) & (K Dose)
5.2.3 Global Biosimilar Drug Sales Market Share by Type (2019-2030)
5.3 Global Biosimilar Drug Price by Type
6 Biosimilar Drug Market by Application
6.1 Global Biosimilar Drug Revenue by Application
6.1.1 Global Biosimilar Drug Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Biosimilar Drug Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Biosimilar Drug Revenue Market Share by Application (2019-2030)
6.2 Global Biosimilar Drug Sales by Application
6.2.1 Global Biosimilar Drug Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Biosimilar Drug Sales by Application (2019-2030) & (K Dose)
6.2.3 Global Biosimilar Drug Sales Market Share by Application (2019-2030)
6.3 Global Biosimilar Drug Price by Application
7 Company Profiles
7.1 CP Guojian Pharma
7.1.1 CP Guojian Pharma Comapny Information
7.1.2 CP Guojian Pharma Business Overview
7.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 CP Guojian Pharma Biosimilar Drug Product Portfolio
7.1.5 CP Guojian Pharma Recent Developments
7.2 Biotech Pharma
7.2.1 Biotech Pharma Comapny Information
7.2.2 Biotech Pharma Business Overview
7.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Biotech Pharma Biosimilar Drug Product Portfolio
7.2.5 Biotech Pharma Recent Developments
7.3 Celgen Pharma
7.3.1 Celgen Pharma Comapny Information
7.3.2 Celgen Pharma Business Overview
7.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Celgen Pharma Biosimilar Drug Product Portfolio
7.3.5 Celgen Pharma Recent Developments
7.4 Henlius
7.4.1 Henlius Comapny Information
7.4.2 Henlius Business Overview
7.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Henlius Biosimilar Drug Product Portfolio
7.4.5 Henlius Recent Developments
7.5 Amgen
7.5.1 Amgen Comapny Information
7.5.2 Amgen Business Overview
7.5.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Amgen Biosimilar Drug Product Portfolio
7.5.5 Amgen Recent Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Comapny Information
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Eli Lilly Biosimilar Drug Product Portfolio
7.6.5 Eli Lilly Recent Developments
7.7 Sandoz
7.7.1 Sandoz Comapny Information
7.7.2 Sandoz Business Overview
7.7.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Sandoz Biosimilar Drug Product Portfolio
7.7.5 Sandoz Recent Developments
7.8 Changchun High Tech
7.8.1 Changchun High Tech Comapny Information
7.8.2 Changchun High Tech Business Overview
7.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Changchun High Tech Biosimilar Drug Product Portfolio
7.8.5 Changchun High Tech Recent Developments
7.9 Innovent
7.9.1 Innovent Comapny Information
7.9.2 Innovent Business Overview
7.9.3 Innovent Biosimilar Drug Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Innovent Biosimilar Drug Product Portfolio
7.9.5 Innovent Recent Developments
8 North America
8.1 North America Biosimilar Drug Market Size by Type
8.1.1 North America Biosimilar Drug Revenue by Type (2019-2030)
8.1.2 North America Biosimilar Drug Sales by Type (2019-2030)
8.1.3 North America Biosimilar Drug Price by Type (2019-2030)
8.2 North America Biosimilar Drug Market Size by Application
8.2.1 North America Biosimilar Drug Revenue by Application (2019-2030)
8.2.2 North America Biosimilar Drug Sales by Application (2019-2030)
8.2.3 North America Biosimilar Drug Price by Application (2019-2030)
8.3 North America Biosimilar Drug Market Size by Country
8.3.1 North America Biosimilar Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Biosimilar Drug Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Biosimilar Drug Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 Europe
9.1 Europe Biosimilar Drug Market Size by Type
9.1.1 Europe Biosimilar Drug Revenue by Type (2019-2030)
9.1.2 Europe Biosimilar Drug Sales by Type (2019-2030)
9.1.3 Europe Biosimilar Drug Price by Type (2019-2030)
9.2 Europe Biosimilar Drug Market Size by Application
9.2.1 Europe Biosimilar Drug Revenue by Application (2019-2030)
9.2.2 Europe Biosimilar Drug Sales by Application (2019-2030)
9.2.3 Europe Biosimilar Drug Price by Application (2019-2030)
9.3 Europe Biosimilar Drug Market Size by Country
9.3.1 Europe Biosimilar Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Biosimilar Drug Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Biosimilar Drug Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Biosimilar Drug Market Size by Type
10.1.1 China Biosimilar Drug Revenue by Type (2019-2030)
10.1.2 China Biosimilar Drug Sales by Type (2019-2030)
10.1.3 China Biosimilar Drug Price by Type (2019-2030)
10.2 China Biosimilar Drug Market Size by Application
10.2.1 China Biosimilar Drug Revenue by Application (2019-2030)
10.2.2 China Biosimilar Drug Sales by Application (2019-2030)
10.2.3 China Biosimilar Drug Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Biosimilar Drug Market Size by Type
11.1.1 Asia Biosimilar Drug Revenue by Type (2019-2030)
11.1.2 Asia Biosimilar Drug Sales by Type (2019-2030)
11.1.3 Asia Biosimilar Drug Price by Type (2019-2030)
11.2 Asia Biosimilar Drug Market Size by Application
11.2.1 Asia Biosimilar Drug Revenue by Application (2019-2030)
11.2.2 Asia Biosimilar Drug Sales by Application (2019-2030)
11.2.3 Asia Biosimilar Drug Price by Application (2019-2030)
11.3 Asia Biosimilar Drug Market Size by Country
11.3.1 Asia Biosimilar Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Biosimilar Drug Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Biosimilar Drug Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Biosimilar Drug Market Size by Type
12.1.1 MEALA Biosimilar Drug Revenue by Type (2019-2030)
12.1.2 MEALA Biosimilar Drug Sales by Type (2019-2030)
12.1.3 MEALA Biosimilar Drug Price by Type (2019-2030)
12.2 MEALA Biosimilar Drug Market Size by Application
12.2.1 MEALA Biosimilar Drug Revenue by Application (2019-2030)
12.2.2 MEALA Biosimilar Drug Sales by Application (2019-2030)
12.2.3 MEALA Biosimilar Drug Price by Application (2019-2030)
12.3 MEALA Biosimilar Drug Market Size by Country
12.3.1 MEALA Biosimilar Drug Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Biosimilar Drug Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Biosimilar Drug Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Biosimilar Drug Value Chain Analysis
13.1.1 Biosimilar Drug Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Biosimilar Drug Production Mode & Process
13.2 Biosimilar Drug Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Biosimilar Drug Distributors
13.2.3 Biosimilar Drug Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings